Latest news
The New AIM Rules: Key Changes for Companies - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 19:38:19 GMTVir Biotechnology (VIR): State Street discloses 9.96M-share, 5.9% ownership position - Stock TitanStock Titan · Fri, 07 Aug 2026 15:11:21 GMTKane reviews options; wound-care activity began in U.S. and Canada - Stock TitanStock Titan · Wed, 05 Aug 2026 11:25:00 GMTFSS tightens Korea biotech disclosures, industry warns of IPO chill and strain - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 03 Aug 2026 21:01:00 GMTUSDA’s 2026 Unified Agenda Includes Biobased Product and Biotechnology Rulemakings - JD SupraJD Supra · Mon, 03 Aug 2026 17:51:05 GMTKorea tightens bio disclosures, standardizes IPO pricing to aid investors - CHOSUNBIZ - ChosunbizChosunbiz · Thu, 30 Jul 2026 07:00:00 GMTThe 'Dream Drug' Label Fades: South Korea's FSS Overhauls Pharma and Biotech Disclosure Rules - finance.biggo.comfinance.biggo.com · Thu, 30 Jul 2026 04:05:00 GMTKorea Overhauls Pharma-Bio Disclosure Rules to Clarify IPO Pricing - Seoul Economic DailySeoul Economic Daily · Thu, 30 Jul 2026 03:00:05 GMT